The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals

NCT05370677 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2022-05-11

No results posted yet for this study

Summary

1. \- To design an amplification-refractory mutation system (ARMS) for the DNA diagnosis of the IVS I-6 (T\>C) mutation.
2. \- To detect the prevelence of the mutation among Assiut University Hospital patients.
3. \- Phenotype/genotype correlation of the mutation.

Conditions

Interventions

GENETIC

ARMS

amplification refractory mutation system

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2024-09-30
Completion
2024-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05370677 on ClinicalTrials.gov